MLAB vs DRUG

Comparison between Mesa Laboratories Inc (MLAB, Company) and Bright Minds Biosciences Inc (DRUG, Company).

MLAB is from the Technology sector, while DRUG is from the Healthcare sector.

5-Year PerformanceDRUG has outperformed MLAB, delivering a return of +22.2% compared to -16.3%

MLAB vs DRUG - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	MLAB(COMPANY)	DRUG(COMPANY)
Market Cap	$592M	$590M
Max Drawdown	82.72%	97.68%
Sharpe Ratio	0.32	1.37
5Y Beta	1.50	-0.81
Industry	Scientific & Technical Instruments	Biotechnology
P/E Ratio	87.91	-25.02
Forward P/E	35.21	N/A
PEG Ratio	0.00	-0.07
Dividend Yield	0.59%	N/A
5Y Dividends CAGR	4.56%	N/A
5Y EPS CAGR	N/A	8.42%
Debt to Equity	36.24%	0.03%
Free Cash Flow Yield	6.68%	-2.46%
P/S Ratio	2.42	N/A
P/B Ratio	3.23	2.73

Market Cap

Winner

MLAB

$592M

DRUG

$590M

Max Drawdown

Winner

MLAB

82.72%

DRUG

97.68%

Sharpe Ratio

MLAB

0.32

Winner

DRUG

1.37

5Y Beta

MLAB

1.50

Winner

DRUG

-0.81

Industry

MLAB

Scientific & Technical Instruments

DRUG

Biotechnology

P/E Ratio

MLAB

87.91

Winner

DRUG

-25.02

Forward P/E

MLAB

35.21

DRUG

N/A

PEG Ratio

MLAB

0.00

Winner

DRUG

-0.07

Dividend Yield

MLAB

0.59%

DRUG

N/A

5Y Dividends CAGR

MLAB

4.56%

DRUG

N/A

5Y EPS CAGR

MLAB

N/A

DRUG

8.42%

Debt to Equity

MLAB

36.24%

Winner

DRUG

0.03%

Free Cash Flow Yield

Winner

MLAB

6.68%

DRUG

-2.46%

P/S Ratio

MLAB

2.42

DRUG

N/A

P/B Ratio

MLAB

3.23

Winner

DRUG

2.73

MLAB vs DRUG - Historical Returns

Returns include dividend reinvestment.

Period	MLAB	DRUG
1 month	+1.89%	-28.00%
3 months	+35.77%	-15.64%
6 months	+36.07%	-27.60%
1 year	+6.40%	+114.76%
5 years(CAGR)	-16.35%	+22.21%
10 years(CAGR)	-0.99%	N/A
Max(CAGR)	+14.31%	+16.87%

Winner

MLAB

+1.89%

DRUG

-28.00%

Winner

MLAB

+35.77%

DRUG

-15.64%

Winner

MLAB

+36.07%

DRUG

-27.60%

MLAB

+6.40%

Winner

DRUG

+114.76%

5Y(CAGR)

MLAB

-16.35%

Winner

DRUG

+22.21%

10Y(CAGR)

MLAB

-0.99%

DRUG

N/A

Max(CAGR)

MLAB

+14.31%

Winner

DRUG

+16.87%

MLAB vs DRUG - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

Year	MLAB	DRUG
2026	+33.22%	-26.97%
2025	-40.09%	+89.83%
2024	+24.81%	+1859.10%
2023	-38.85%	-63.33%
2022	-49.32%	-78.04%
2021	+17.79%	-41.30%
2020	+15.41%	N/A
2019	+20.50%	N/A
2018	+67.64%	N/A
2017	+0.93%	N/A
2016	+23.37%	N/A
2015	+25.15%	N/A
2014	+1.41%	N/A
2013	+50.43%	N/A
2012	+22.84%	N/A
2011	+39.54%	N/A
2010	+15.72%	N/A
2009	+45.62%	N/A
2008	-31.35%	N/A
2007	+34.17%	N/A
2006	+29.17%	N/A
2005	+19.22%	N/A
2004	+31.61%	N/A
2003	+56.36%	N/A
2002	+7.12%	N/A
2001	-3.84%	N/A
2000	+57.48%	N/A
1999	-4.67%	N/A

MLAB vs DRUG Drawdown Comparison

The maximum drawdown for MLAB was -82.43%, occurring on Aug 5, 2025. This drawdown has not yet recovered.

The maximum drawdown for DRUG was -97.68%, occurring on Jul 11, 2024. Recovery took 740 trading sessions.

The current MLAB drawdown is -67.49%. The current DRUG drawdown is -36.50%.

Rank	MLAB	DRUG
#1	-82.43% Dec 27, 2021 - Aug 5, 2025	-97.68% Nov 8, 2021 - Oct 18, 2024
#2	-43.68% Jan 9, 2008 - Dec 29, 2009	-58.28% Nov 6, 2024 - Sep 29, 2025
#3	-41.25% Mar 21, 2014 - Jul 20, 2015	-36.50% Jan 7, 2026 - Jun 12, 2026
#4	-36.60% Nov 2, 2000 - Jan 23, 2002	-27.84% Mar 22, 2021 - Aug 24, 2021
#5	-34.53% Aug 3, 2015 - Jun 6, 2016	-26.13% Oct 21, 2025 - Nov 28, 2025
#6	-31.00% Jul 23, 2007 - Jan 2, 2008	-19.30% Dec 16, 2025 - Jan 7, 2026
#7	-29.55% Apr 2, 2002 - Jul 28, 2003	-16.21% Sep 30, 2025 - Oct 9, 2025
#8	-29.39% Feb 6, 2020 - Oct 7, 2020	-14.42% Oct 11, 2021 - Nov 3, 2021
#9	-28.63% May 6, 2019 - Jan 14, 2020	-9.05% Oct 24, 2024 - Nov 4, 2024
#10	-27.52% Jan 12, 2010 - Dec 27, 2010	-7.65% Oct 14, 2025 - Oct 21, 2025
#11	-25.39% Jun 5, 2017 - Apr 13, 2018	-5.42% Dec 11, 2025 - Dec 16, 2025
#12	-25.23% Mar 12, 2012 - Jul 11, 2013	-4.62% Sep 24, 2021 - Sep 29, 2021
#13	-23.23% Jul 12, 2018 - Jan 31, 2019	-4.59% Dec 8, 2025 - Dec 10, 2025
#14	-22.38% Oct 18, 2004 - Nov 8, 2005	-4.38% Aug 24, 2021 - Sep 1, 2021
#15	-21.14% Jun 9, 2016 - Nov 17, 2016	-3.81% Sep 1, 2021 - Sep 17, 2021